Navigation Links
Effect of Strict Diabetes Control on Heart Still Unclear

Reviews show it wasn't to blame for excess deaths in one trial, but when therapy starts could be key

TUESDAY, June 9 (HealthDay News) -- Reviews of two large diabetes trials show that the relationship between tight blood sugar control and the risk of heart trouble is still far from certain.

The first analysis found that a troubling number of deaths seen in a large diabetes trials appears not to have been caused by low blood glucose levels, as originally thought.

It's still not completely clear, however, what factors might explain the 451 deaths that occurred in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, which was shut down early after researchers found a 20 percent increased risk of death among those in the more intensive blood sugar control group.

Meanwhile, analyses of another trial, the VA Diabetes (VADT) trial, found that intensive blood sugar control that's begun many years after diagnosis may actually do more harm than good when it comes to cardiovascular problems.

Both sets of analyses, which were presented Tuesday during a teleconference at the American Diabetes Association (ADA) annual meeting in New Orleans, suggest that diabetes treatment needs to be tailored to the particular needs and characteristics of each patient.

"Treatment should be individualized," Dr. William C. Duckworth, VADT co-chair and director of diabetes research at the Carl T. Hayden VA Medical Center in Phoenix, said during the Tuesday teleconference. "Type 2 diabetes is an extremely heterogenous disease, so if you treat different populations or different groups within the population you're studying you may get different results."

"We are withholding specific recommendations, but there may be potentially different glucose-control targets for different groups of people," added Dr. Matthew C. Riddle, member of the ACCORD Glycemia Management Group and professor of medicine at Oregon Health Science University. "If we can objectively identify which individuals fall into which groups, that would be a big step forward."

Type 2 diabetes, which affects some 24 million Americans, can result in devastating complications such as kidney disease, amputation, blindness and heart disease. A common test for measuring blood sugar levels looks at hemoglobin A1C values spread over two to three months.

"The central role of glucose control in preventing microvascular eye, kidney and nerve disease is fairly well-established," said Dr. Rick Bergenstahl, executive director of the International Diabetes Center in Minneapolis and ADA's president-elect of medicine and science. "Data related to macrovascular effects on the heart are less well understood or less conclusive."

Research presented last year on the ACCORD trial found that intensive lowering of blood sugar in people with poorly controlled type 2 diabetes did not have a significant effect on reducing cardiovascular events, such as heart attack and stroke. In fact, it appeared to raise the risk of death.

At the time, scientists speculated that the increased mortality risk was due to low blood sugar, but this turned out not to be the case.

Instead, "people who achieved a rapid and sustained reduction of A1C from higher levels at the beginning had the lower risk, and the ones who were unable to rapidly reduce glucose from the beginning had the higher risk," Riddle explained. In other words, those who struggled to get their glucose under control seem to be at higher risk for heart trouble.

Meanwhile, analyses from the VADT trial indicates that intensive diabetes treatment begun earlier after a diagnosis is more likely to do good, while intensive treatment started 15 years after diagnosis is more likely to do harm.

Starting rigorous control of blood sugar two decades or more after a diagnosis of diabetes actually upped the risk of cardiovascular problems, at least in this population of mostly older males.

Similar to the ACCORD trial, the authors reported no beneficial effect of intensive glucose control on cardiovascular events and, ever since, have been trying to figure out why.

One message, however, is that tight blood sugar control is not bad overall, which is in line with previous thinking.

"The closer to normal range the better, and that is what we've been recommending all along," said Dr. Helena W. Rodbard, past president of both the American Association of Clinical Endocrinologists and the American College of Endocrinology. "We have to aim for good control, but good control early on."

More information

Visit the American Diabetes Association for more on type 2 diabetes.

SOURCES: Helena W. Rodbard, M.D., medical director, Endocrine and Metabolic Consultants, Rockville, Md., past-president, American Association of Clinical Endocrinologists and past president, American College of Endocrinology; June 9, 2009, teleconference with Richard M. Bergenstahl, M.D., executive director, International Diabetes Center, Minneapolis; Matthew C. Riddle, M.D., professor, medicine, Oregon Health Science University, and member, ACCORD Glycemia Management Group; and William C. Duckworth, M.D., director, diabetes research, Carl T. Hayden VA Medical Center, Phoenix, and professor, clinical medicine, University of Arizona, and co-chair, VA Diabetes Trial

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Use of certain lipid measures not more effective in predicting coronary heart disease
3. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
4. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
5. Stanford study highlights cost-effective method of lowering heart disease risks
6. New study may explain Vioxx side-effects
7. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
8. Case Management Cost-Effective Way to Cut Heart Risks
9. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
10. Nasal Anthrax Vaccine Proves Effective in Animal Study
11. Family-based treatment more effective than supportive psychotherapy in treating bulimia
Post Your Comments:
Related Image:
Effect of Strict Diabetes Control on Heart Still Unclear
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/25/2015)... ... , ... The holiday season is jam-packed with family dinners, ... attendees is of the utmost importance. Whether you are cooking at home for ... a try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and public R&D ... Nairobi (UNON) for the opening of the 5th African Network for Drugs and ...
(Date:11/25/2015)... ... , ... Dental professionals who would like to become more proficient on their ... Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on December ... of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to announce ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased to ... facial wrinkling. While many patients are aware of the benefits of Botox® in the ... to those suffering with discomfort, soreness, and pain as a result of Jaw Tension, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
(Date:11/25/2015)... ) ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
Breaking Medicine Technology: